MONTREAL--(BUSINESS WIRE)-- Illumiti, a Syntax company, today announced it is the recipient of an SAP® North America Partner Excellence Award 2023 for Cloud Delivery Excellence. Awards were presented ...
The Science Advances publication details Cellgorithmâ„¢, a CRISPR-based technology that gives researchers greater control over gene activity and sets the stage for future applications in stem cell ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a preclinical-stage biotechnology company, has launched with backing from Astellas Venture Management LLC and Illumina Ventures. Other investors include DCVCBio, ...